The Nociceptive Flexion Reflex as a Diagnostic Tool of Central Sensitization
NFR-CS
De Nociceptieve Flexie Reflex Als Diagnostische Test Voor Centrale Sensitisatie
1 other identifier
observational
240
1 country
1
Brief Summary
This experimental study will investigate whether the decreased NFR threshold and increased NFR temporal summation, which are frequently observed in chronic pain patients, are only symptomatic manifestations that occur in the involved limb and indicate peripheral sensitization or generalized manifestations that are also present in the non-involved limbs and thus indicate central sensitization. To gain an idea of the presence of central sensitization, this study will also investigate whether there are increased perception and decreased pain thresholds in response to electrical, thermal, and mechanical stimulation, as well as whether there is a decreased conditioned pain modulation. To investigate this, it is essential to examine different pain populations and locations, in particular, acute pain versus chronic pain populations to compare peripheral versus central sensitization, respectively. Recently, our research group has shown that patients with a traumatic origin of chronic neck pain (chronic whiplash-associated disorders) show central sensitization in contrast to patients with a non-traumatic origin (chronic idiopathic neck pain) who demonstrate only indications for peripheral sensitization. Therefore, this study will also distinguish between complaints of traumatic and non-traumatic origin. The measurements will be performed at different locations, namely the lower and upper limbs. To determine whether the differences depend on the measurement location (= location where experimental nociceptive stimulation is administered) and symptom location (= location of clinical nociceptive stimulation), different patient populations will be compared with each other, as well as with a healthy control population. In acute and chronic whiplash patients and patients with acute and chronic idiopathic neck pain complaints, the complaints are primarily localized in the upper limb. It is hypothesized that in chronic neck pain patients (both whiplash and idiopathic neck pain patients) abnormal values are found in both the upper and lower limbs compared to the healthy controls due to central sensitization. In acute neck pain patients (both whiplash and idiopathic neck pain) only abnormal values in the arm are expected and not in the leg as a result of peripheral sensitization. It is hypothesized that patients with neck pain of traumatic origin will show a stronger sensitization than those with neck pain of non-traumatic origin. In acute and chronic low back pain patients, the complaints are primarily localized in the lower body quadrant. As a result of central sensitization in the chronic low back pain patients, abnormal values are expected in both the upper and lower limbs, while only abnormal values in the leg are expected as a result of peripheral sensitization in the acute low back pain patients. Finally, this study will investigate whether chronic low back and neck pain patients show a similar pattern of central sensitization as fibromyalgia patients, a population with generalized complaints that are primarily attributed to central sensitization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2022
CompletedFirst Posted
Study publicly available on registry
April 11, 2022
CompletedStudy Start
First participant enrolled
April 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedJanuary 5, 2024
January 1, 2024
2.4 years
March 22, 2022
January 4, 2024
Conditions
Outcome Measures
Primary Outcomes (12)
Quantitative sensory testing (QST) - electrical detection threshold
Determination of sensory detection thresholds in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.
Baseline
Quantitative sensory testing (QST) - electrical pain threshold
Determination of sensory pain threshold in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.
Baseline
Quantitative sensory testing (QST) - thermal detection threshold
Determination of sensory detection thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: * cold detection threshold * warmth detection threshold
Baseline
Quantitative sensory testing (QST) - thermal pain threshold
Determination of sensory pain thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C: * cold pain threshold * heat pain threshold
Baseline
Quantitative sensory testing (QST) - discrimination between thermal stimuli
Determination of the number of paradoxical heat sensations in response to alternating cold and warm stimuli delivered to the skin using a thermode.
Baseline
Quantitative sensory testing (QST) - tactile detection threshold
Determination of tactile detection threshold, assessed using Von Frey monofilaments, recorded in mN
Baseline
Quantitative sensory testing (QST) - mechanical pain threshold
Determination of mechanical pain threshold, assessed using pinprick stimulators, recorded in mN
Baseline
Quantitative sensory testing (QST) - sensitivity to pressure stimuli
Determination of pressure pain threshold, assessed using pressure algometry, recorded in kg
Baseline
Quantitative sensory testing (QST) - temporal summation of electrical stimuli
Determination of temporal summation in response to electrical stimuli delivered transcutaneously over the skin of the n. suralis and n. medianus. The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded.
Baseline
Quantitative sensory testing (QST) - spinal hyperexcitability
Determination of spinal hyperexcitability using the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded in mA
Baseline
Quantitative sensory testing (QST) - temporal summation of spinal hyperexcitability
Determination of temporal summation of the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded using a numeric pain rating scale (range 0 - 100)
Baseline
Quantitative sensory testing - conditioned pain modulation
Determination of condition pain modulation (aka. pain inhibits pain) by means of a heterotopic noxious counterstimulation paradigm. Test stimuli comprise of pressure pain threshold assessments and application of a heat stimulus (using a thermode) corresponding to a temperature eliciting a visual analog scale rating of 5/10. Test stimuli will be applied before, during and after the conditioning stimulus which is the immersion of the hand in a hot circulating water bath of 45.5°C.
Baseline
Secondary Outcomes (14)
Central sensitization inventory
Baseline
Douleur Neuropathique 4 Questionnaire
Baseline
Pain catastrophizing scale
Baseline
Pain vigilance and awareness questionnaire
Baseline
Tampa scale for kinesiophobia
Baseline
- +9 more secondary outcomes
Study Arms (4)
Fibromyalgia patients
Fibromyalgia patients diagnosed according to the 2010 ACR-criteria
Neck pain patients
* Patients with non-specific, idiopathic neck pain complaints * Patients with neck pain complaints of traumatic origin type whiplash grade 1 (pain, stiffness or tenderness of the neck and no objective physical abnormalities) and grade 2 (neck complaints and musculoskeletal disorders such as reduced range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders
Low back pain patients
Patients with non-specific, idiopathic back pain complaints
Healthy controls
Age, sex and BMI-matched healthy controls
Eligibility Criteria
* Fibromyalgia patients (n=30) diagnosed according to the 2010 ACR-criteria * Patients with non-specific, idiopathic neck pain complaints which are acute (n=30) or chronic (n=30) * Patients with neck pain complaints of traumatic origin type whiplash grade 1 (pain, stiffness or tenderness of the neck and no objective physical abnormalities) and grade 2 (neck complaints and musculoskeletal disorders such as reduced range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders which is acute (n=30) or chronic (n=30) * Patients with non-specific, idiopathic back pain complaints which are acute (n=30) or chronic (n=30) * Healthy controls (n=30) matched based on age, sex and BMI
You may qualify if:
- \- diagnosed according to 2010 ACR-criteria
- \- having idiopathic neck pain complaints or having grade 1 (pain, stiffness or tenderness of the neck and without objective physical abnormalities) or grade 2 (neck complaints and musculoskeletal disorders such as decreased range of motion and tender pain points) according to the Quebec Task Force on Whiplash Associated Disorders
- \- having idiopathic low back pain complaints
- no history of serious pain complaints (e.g. severe migraine, fibromyalgia, etc.)
- no low back or neck pain complaints with an intensity of ≥2/10 on a visual analogue scale in the past year and of such severity that the daily activities were disrupted and a (para)medic was consulted
You may not qualify if:
- history of severe respiratory (e.g. cystic fibrosis), orthopedic (e.g. whiplash trauma), neurological (e.g. cerebrovascular incident), cardiovascular (e.g. severe hypertension), or endocrinological (e.g. diabetes) disorders
- recent psychological trauma (e.g. post-traumatic stress disorder)
- history of spinal surgery (e.g. lumbar discectomy), spinal trauma (e.g. vertebral fracture), or severe spinal deformities (e.g. spondylolisthesis)
- BMI ≥35 (due to potential difficulties in obtaining an NFR in severely overweight individuals)
- pregnancy, lactation, or within 1 year postpartum
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (1)
Ghent University
Ghent, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Van Oosterwijck
University Ghent
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2022
First Posted
April 11, 2022
Study Start
April 21, 2022
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
January 5, 2024
Record last verified: 2024-01